<DOC>
	<DOCNO>NCT00573924</DOCNO>
	<brief_summary>Patients bleed ulcer identify endoscopy randomly assign receive acid-blocking drug ( call proton pump inhibitor [ PPI ] ) either mouth every 3 hour 24 hour intravenously ( IV ) constant infusion 24 hour . A pH probe stomach use determine intragastric pH ( measure acid production stomach ) baseline 24 hour therapy . The purpose study determine continuous intravenous administration drug provide good reduction acid stomach oral administration .</brief_summary>
	<brief_title>Trial Oral Versus Intravenous Proton Pump Inhibitor Intragastric pH Patients With Bleeding Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>Patients present hospital overt upper GI bleeding find ulcer cause endoscopy Previous gastric surgery Active bleed end endoscopy ( despite hemostatic therapy ) Recent PPI H2RA use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>